Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. Wikipedia
Headquarters: Mechelen, Belgium
CEO: Paul Stoffels (Apr 2022–)
Subsidiaries: Abound Bio, Inc., CellPoint B.V., Galapagos, Inc., and more
Founder: Onno van de Stolpe
Founded: 1999
Formerly: Galapagos Genomics NV
Source: S&P Global Market Intelligence
People also ask
What does Galapagos NV do?
Where is Galapagos Pharma located?
What is the history of Galapagos company?
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations ...
Jul 14, 2019 · Galapagos NV (Euronext & NASDAQ: GLPG) today announced that they have entered into a 10-year global research and development collaboration ...
We are a biotechnology company with operations in Europe and the U.S. dedicated to developing transformational medicines for more years of life and quality ...
Galapagos NV (Galapagos) is a clinical-stage biotechnology company that specializes in the discovery and development of small-molecule medicines.
Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action, ...